Product Information
Registration Status: ActiveSIN14309P
NIMBEX INJECTION 2mg/ML is approved to be sold in Singapore with effective from 2013-05-02. It is marketed by DCH AURIGA SINGAPORE, with the registration number of SIN14309P.
This product contains Cisatracuriuml 2mg/ml in the form of INJECTION, SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by GlaxoSmithKline Manufacturing S.p.A. in ITALY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.